Enquire Now
Home
About
Company Overview
Leadership
Sustainability
Overview
Health & Safety
Environment
Responsible Workforce
Ethics
Social Commitment
Responsible Procurement
Compliance
Sustainability Reports
Facilities
Quality
Accreditations
CSR
CDMO Services
Products
Overview
API
Intermediates
Caffeine
Xanthine Derivatives
Acid & Allied
R&D
Investor
Overview
Disclosure
Financial Information
Corporate Governance
Shareholders Information
Code and Policies
Downloads
Annual Reports
Resources
Latest News
Events
Career
Why Aarti Pharmalabs
Job Openings
Contact
Q3 FY 25 Results
Home
Investors
Financial Information
Concalls
Q3 FY 25 Results
Investor Menu
Overview
Disclosure
Financial Information
Corporate Governance
Shareholders Information
Code and Policies
Downloads
Annual Reports
Quarterly Results
Presentation
Concalls
Financial Hightlights
Subsidiary Companies Balance Sheets
Press Releases
Memorandum and Articles of Association
Annual Return
Conference Call
Q1 FY 24
Q2 FY 24
Q3 FY 24
Q4 FY 24
Q1 FY 25
Q2 FY 25
Q3 FY 25
Q4 FY25
Q1 FY 26
Q2 FY 26
Q3 FY 26
Q4 FY 26
Sort
Latest
Oldest
Year
2026
2025
Q3 FY 25 Earnings call Initimation
January 28, 2025
Q3 FY 25 Earnings Concall
June 01, 2026
Q3 Earning call Transcript
February 12, 2025
Let’s Build the Future of
Healthcare Together
Contact Us
Investor Menu
January 28, 2025